Neuroscience

Poorer neuropsychological test scores for HIV-positive

(HealthDay)—HIV-positive individuals treated with combination antiretroviral therapy (cART) have poorer neuropsychological test scores than controls but no significant neuropsychological decline over time, according to ...

Oncology & Cancer

For cancer patients with HIV, immunotherapy appears safe

A new category of immunotherapies called checkpoint inhibitors that has been highly effective against many different cancers appears safe to use in patients with both advanced malignancies and HIV, a population excluded from ...

Diseases, Conditions, Syndromes

HIV drug resistance is threatening gains of treatment

(HealthDay)—Resistance to antiretroviral therapy (ART) is threatening the recent gains of treatment in the rate of new HIV infections, according to a perspective article published online Oct. 25 in the New England Journal ...

Medical research

Reengineered immune system cells show early promise against HIV

Improving on a previous attempt, scientists have developed a new strategy that could potentially be used to reengineer a patient's own immune system cells to fight HIV. The approach, described in PLOS Pathogens, shows benefit ...

Diseases, Conditions, Syndromes

HIV: The benefits of prophylaxis of tuberculosis are confirmed

A long-term follow-up study in the ANRS TEMPRANO trial confirms that tuberculosis chemoprophylaxis in HIV-infected people is more than ever relevant in resource-limited countries. This prophylactic use of drugs reduces mortality, ...

HIV & AIDS

Researchers create molecule that could 'kick and kill' HIV

Current anti-AIDS drugs are highly effective at making HIV undetectable and allowing people with the virus to live longer, healthier lives. The treatments, a class of medications called antiretroviral therapy, also greatly ...

page 28 from 40